Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,390,020
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
2,337,881
-
Shares change
-
-823,560
-
Total reported value, excl. options
-
$2,428,000
-
Value change
-
-$2,445,760
-
Put/Call ratio
-
52.4%
-
Number of buys
-
14
-
Number of sells
-
-9
-
Price
-
$1.04
Significant Holders of Arcadia Biosciences, Inc. - Common Stock (RKDA) as of Q4 2021
32 filings reported holding RKDA - Arcadia Biosciences, Inc. - Common Stock as of Q4 2021.
Arcadia Biosciences, Inc. - Common Stock (RKDA) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,337,881 shares
.
Largest 10 shareholders include VANGUARD GROUP INC (789,931 shares), RENAISSANCE TECHNOLOGIES LLC (338,600 shares), SABBY MANAGEMENT, LLC (252,953 shares), GEODE CAPITAL MANAGEMENT, LLC (168,337 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (155,514 shares), MYDA Advisors LLC (100,000 shares), CITADEL ADVISORS LLC (64,602 shares), BlackRock Inc. (60,190 shares), STATE STREET CORP (56,200 shares), and LPL Financial LLC (44,000 shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.